- Home
- CSTE vs CRVO Comparison
CSTE vs CRVO Comparison
Compare CSTE & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- CRVO
- Stock Information
- Founded
- CSTE 1987
- CRVO 2001
- Country
- CSTE Israel
- CRVO United States
- Employees
- CSTE N/A
- CRVO N/A
- Industry
- CSTE Building Materials
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CSTE Industrials
- CRVO Health Care
- Exchange
- CSTE Nasdaq
- CRVO Nasdaq
- Market Cap
- CSTE 61.9M
- CRVO 67.4M
- IPO Year
- CSTE 2012
- CRVO N/A
- Fundamental
- Price
- CSTE $1.19
- CRVO $7.46
- Analyst Decision
- CSTE
- CRVO Strong Buy
- Analyst Count
- CSTE 0
- CRVO 6
- Target Price
- CSTE N/A
- CRVO $19.17
- AVG Volume (30 Days)
- CSTE 103.0K
- CRVO 110.5K
- Earning Date
- CSTE 11-12-2025
- CRVO 11-12-2025
- Dividend Yield
- CSTE N/A
- CRVO N/A
- EPS Growth
- CSTE N/A
- CRVO N/A
- EPS
- CSTE N/A
- CRVO N/A
- Revenue
- CSTE $406,178,000.00
- CRVO $7,776,968.00
- Revenue This Year
- CSTE N/A
- CRVO N/A
- Revenue Next Year
- CSTE $5.61
- CRVO N/A
- P/E Ratio
- CSTE N/A
- CRVO N/A
- Revenue Growth
- CSTE N/A
- CRVO N/A
- 52 Week Low
- CSTE $1.13
- CRVO $1.80
- 52 Week High
- CSTE $5.04
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- CSTE 28.72
- CRVO 40.12
- Support Level
- CSTE $1.13
- CRVO $6.70
- Resistance Level
- CSTE $1.48
- CRVO $7.15
- Average True Range (ATR)
- CSTE 0.10
- CRVO 0.38
- MACD
- CSTE -0.02
- CRVO -0.02
- Stochastic Oscillator
- CSTE 12.20
- CRVO 20.91
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.